Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT04726033
What this trial is testing

64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 14
Not applicableStudy completedNCT02225925
What this trial is testing

Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Early research (Phase 1)Study completedNCT01103310
What this trial is testing

Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation

Who this might be right for
Diagnostic ImagingNeoplasms
Lantheus Biosciences Ltd. 46
Early research (Phase 1)UnknownNCT02496013
What this trial is testing

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Who this might be right for
Arteriovenous MalformationHemangiomaNeoplasms Lymph Nodes+1 more
Peking Union Medical College Hospital 70
Early research (Phase 1)Looking for participantsNCT07580703
What this trial is testing

A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy

Who this might be right for
AD - Alzheimer's DiseaseMCI
Eli Radiopharma 18
Early research (Phase 1)Study completedNCT02240290
What this trial is testing

Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant

Who this might be right for
N/A, as Healthy Volunteers
Biotie Therapies Inc. 6
Early research (Phase 1)Ended earlyNCT05977322
What this trial is testing

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastroesophageal AdenocarcinomaGlioblastoma Multiforme
Novartis Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00250172
What this trial is testing

PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

Who this might be right for
DosimetryHealthy
National Institute of Mental Health (NIMH) 26
Not applicableEnrolling By InvitationNCT03755245
What this trial is testing

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

Who this might be right for
Healthy SubjectsRheumatoid ArthritisVasculitis+1 more
Turku University Hospital 26
Not applicableUnknownNCT06201741
What this trial is testing

Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer
Huashan Hospital 10
Not applicableUnknownNCT03974256
What this trial is testing

Preparation of Radiopharmaceuticals by Automaton: Operators Dosimetry

Who this might be right for
Exposure, Radiation
Central Hospital, Nancy, France 22
Very early researchNot Yet RecruitingNCT07671092
What this trial is testing

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Who this might be right for
Metastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more
RayzeBio, Inc. 40
Early research (Phase 1)UnknownNCT03403595
What this trial is testing

177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 30
Early research (Phase 1)Study completedNCT00784108
What this trial is testing

Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.

Who this might be right for
Skin CancerSigns and Symptoms
University of California, Irvine 11
Early research (Phase 1)Study completedNCT05410821
What this trial is testing

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Refractory Thyroid Gland CarcinomaRefractory Thyroid Gland Papillary CarcinomaRefractory Thyroid Gland Follicular Carcinoma+1 more
The First Affiliated Hospital of Xiamen University 12
Not applicableLooking for participantsNCT07096999
What this trial is testing

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate Carcinoma
University of Michigan Rogel Cancer Center 60
Early research (Phase 1)Looking for participantsNCT05951816
What this trial is testing

99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

Who this might be right for
Systemic Amyloidosis
University of Tennessee Graduate School of Medicine 31
Early research (Phase 1)Study completedNCT05784597
What this trial is testing

Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors

Who this might be right for
Breast CancerColorectal CancerOesophageal Cancer+1 more
Philogen S.p.A. 18
Not applicableStudy completedNCT06151808
What this trial is testing

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 42
Early research (Phase 1)Study completedNCT00128635
What this trial is testing

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine 22
Next Page